ST7-CAPZA2 Fusion FISH Probe
The ST7-CAPZA2 Fusion FISH Probe is used to confirm a fusion of the ST7 and CAPZA2 genes. The fusion of the ST7 and CAPZA2 genes has been associated with Liver Hepatocellular Carcinoma, Prostate Adenocarcinoma, Kidney Chromophobe, and Prostate Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| ST7-CAPZA2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| ST7-CAPZA2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| ST7-CAPZA2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| ST7-CAPZA2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| ST7-CAPZA2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| ST7-CAPZA2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| ST7-CAPZA2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| ST7-CAPZA2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| ST7-CAPZA2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| ST7-CAPZA2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| ST7-CAPZA2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| ST7-CAPZA2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| ST7-CAPZA2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| ST7-CAPZA2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| ST7-CAPZA2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| ST7-CAPZA2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| ST7-CAPZA2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| ST7-CAPZA2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| ST7-CAPZA2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| ST7-CAPZA2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| ST7-CAPZA2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| ST7-CAPZA2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| ST7-CAPZA2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| ST7-CAPZA2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| ST7-CAPZA2-20-AQAQ | 20 (40 μL) | 200 μL |
|
CAPZA2 Gene Summary
The protein encoded by this gene is a member of the F-actin capping protein alpha subunit family. It is the alpha subunit of the barbed-end actin binding protein Cap Z. By capping the barbed end of actin filaments, Cap Z regulates the growth of the actin filaments at the barbed end. [provided by RefSeq, Jul 2008]
Gene Name: Capping Actin Protein Of Muscle Z-line Alpha Subunit 2
Chromosome: CHR7: 116502562 -116559313
Locus: 7q31.2
ST7 Gene Summary
The gene for this product maps to a region on chromosome 7 identified as an autism-susceptibility locus. Mutation screening of the entire coding region in autistic individuals failed to identify phenotype-specific variants, suggesting that coding mutations for this gene are unlikely to be involved in the etiology of autism. The function of this gene product has not been determined. Transcript variants encoding different isoforms of this protein have been described. [provided by RefSeq, Jul 2008]
Gene Name: Suppression Of Tumorigenicity 7
Chromosome: CHR7: 116593380 -116870075
Locus: 7q31.2
Gene Diseases
The ST7 CAPZA2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Liver Hepatocellular Carcinoma |
| Prostate Adenocarcinoma |
| Kidney Chromophobe |
| Prostate Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|